The Changing CML Treatment Landscape

patientpower has 916 videos Subscribe Here

Loading........
Description: Dr. Jessica Altman, a CML expert from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses the changing treatment landscape in CML and what it means for patients. Dr. Altman explains that there are number of therapies available for newly diagnosed patients and for patients that need to switch therapies due to a lack of optimal response or lack of tolerability to initial treatment. Dr. Altman expresses that this continues to be a positive time in CML and how evolving research will benefit a patient's overall quality of life. Editor's Note (12/20/13): In this interview, Dr. Jessica Altman discuses the drug ponatinib, which, at the time of this interview, had been temporarily pulled from the US market at the request of the Food and Drug Administration (FDA) due to safety concerns. Marketing and distribution of this drug has now resumed in the United States, with updated indication, safety and recommendation information.
Produced in association with Northwestern Medicine

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube | http://www.youtube.com/pati...
Like on Facebook | http://www.fb.com/patientpo...
Follow on Twitter | http://www.twitter.com/pati...
Shared By : patientpower
Posted on : 02/18/14
Added : 10 months ago
Category : General



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)